z-logo
open-access-imgOpen Access
Cutting Edge: Lectin-Like Transcript 1 Is a Ligand for the CD161 Receptor
Author(s) -
Hatice Aldemir,
Virginie Prod’homme,
Marie-Jeanne Dumaurier,
Christelle Retière,
Gwénola Poupon,
Julie Cazareth,
Franck Bihl,
Véronique M. Braud
Publication year - 2005
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.175.12.7791
Subject(s) - receptor , lectin , microbiology and biotechnology , biology , c type lectin , t cell receptor , secretion , cytotoxic t cell , ligand (biochemistry) , t cell , immunology , in vitro , biochemistry , immune system
Human NK cells and subsets of T cells or NKT cells express the orphan C-type lectin receptor CD161 (NKR-P1A) of unknown function. In contrast to rodents that possess several NKR-P1 genes coding for either activating or inhibitory receptors, the nature of signals delivered by the single human NKR-P1A receptor is still to be clarified. In this article, we show that the lectin-like transcript 1 (LLT1) molecule is a ligand for the CD161 receptor. Engagement of CD161 on NK cells with LLT1 expressed on target cells inhibited NK cell-mediated cytotoxicity and IFN-gamma secretion. Conversely, LLT1/CD161 interaction in the presence of a TCR signal enhanced IFN-gamma production by T cells. These findings identify a novel ligand/receptor pair that differentially regulate NK and T cell functions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom